Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in J Investig Allergol Clin Immunol

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    November 2022
  1. HERRERA-LUIS E, Forno E, Celedon JC, Pino-Yanes M, et al
    Asthma exacerbations: the genes behind the scenes.
    J Investig Allergol Clin Immunol. 2022 Nov 24:0. doi: 10.18176/jiaci.0878.
    PubMed     Abstract available


  2. CASTILLA-MARTINEZ M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, et al
    Early effectivity of dupilumab in patients with t2 severe asthma: a prospective real-life study.
    J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0872.
    PubMed    


  3. DOMINGO C, Sicras-Mainar A, Sicras-Navarro A, Sogo A, et al
    Prevalence, T2-biomarkers and cost of severe asthma in the era of biologics: The BRAVO-1 study.
    J Investig Allergol Clin Immunol. 2022 Nov 22:0. doi: 10.18176/jiaci.0871.
    PubMed     Abstract available


  4. MIGUERES N, Vandenplas O, Walusiak-Skorupa J, Wiszniewska M, et al
    Sputum Inflammatory Patterns are Associated with Distinct Clinical Characteristics in Subjects with Occupational Asthma Independently from the Causal Agent.
    J Investig Allergol Clin Immunol. 2022 Nov 8:0. doi: 10.18176/jiaci.0868.
    PubMed     Abstract available


    October 2022
  5. BETANCOR D, Olaguibel JM, Rodrigo-Munoz JM, Alvarez Puebla MJ, et al
    Lung function abnormalities and their correlation with clinical characteristics and inflammatory markers in adult asthma.
    J Investig Allergol Clin Immunol. 2022 Oct 17:0. doi: 10.18176/jiaci.0866.
    PubMed    


  6. ESTEBAN-GORGOJO I, Gorgojo MP, Sastre J, Garcia-Rio F, et al
    The influence of BMI in asthma. Which traits are due to obesity and which to asthma and obesity phenotype?
    J Investig Allergol Clin Immunol. 2022 Oct 6:0. doi: 10.18176/jiaci.0865.
    PubMed     Abstract available


    September 2022
  7. MOYA B, Huang C, Kjarsgaard M, Martin-Arriscado C, et al
    Exhaled breath temperature is not helpful to identify cellular bronchitis in severe asthma.
    J Investig Allergol Clin Immunol. 2022 Sep 29:0. doi: 10.18176/jiaci.0862.
    PubMed    


  8. BANTULA M, Tubita V, Roca-Ferrer J, Mullol J, et al
    Weight loss and vitamin D improve hyporesponsiveness to corticosteroids in obese asthma.
    J Investig Allergol Clin Immunol. 2022 Sep 8:0. doi: 10.18176/jiaci.0861.
    PubMed     Abstract available


  9. MATUCCI A, Micheletto C, Vultaggio A
    Severe asthma and biologics: managing complex patients.
    J Investig Allergol Clin Immunol. 2022 Sep 1:0. doi: 10.18176/jiaci.0856.
    PubMed    


    August 2022
  10. PEREZ DE LLANO L, Cisneros C, Dominguez-Ortega J, Martinez-Moragon E, et al
    Response to monoclonal antibodies in asthma: definitions, potential reasons for failure and therapeutic options for suboptimal response.
    J Investig Allergol Clin Immunol. 2022 Aug 30:0. doi: 10.18176/jiaci.0857.
    PubMed    


  11. MILGER K, Skowasch D, Hamelmann E, Mummler C, et al
    Bronchodilator reversibility in the GAN severe asthma cohort.
    J Investig Allergol Clin Immunol. 2022 Aug 24:0. doi: 10.18176/jiaci.0850.
    PubMed     Abstract available


  12. MELERO MORENO C, Almonacid Sanchez C, Banas Conejero D, Quirce S, et al
    Understanding severe asthma through small and Big Data in Spanish hospitals - PAGE Study.
    J Investig Allergol Clin Immunol. 2022 Aug 24:0. doi: 10.18176/jiaci.0848.
    PubMed     Abstract available


    June 2022
  13. OTANI T, Iwamoto H, Horimasu Y, Yamaguchi K, et al
    Effect of dupilumab in a patient with severe asthma complicated with recurrent anaphylaxis: a case report.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0840.
    PubMed    


  14. ALMONACID SANCHEZ C, Blanco-Aparicio M, Dominguez-Ortega J, Giner Donaire J, et al
    Validation of the algorithm for the monitoring and control of asthma through telemedicine. The Consensus COMETA Project.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0841.
    PubMed    


  15. PEREZ DE LLANO LA, Cosio BG, Lobato Astiarraga I, Soto Campos G, et al
    First line versus second line use of reslizumab in severe uncontrolled asthma.
    J Investig Allergol Clin Immunol. 2022 Jun 27:0. doi: 10.18176/jiaci.0839.
    PubMed    


  16. POSE K, Laorden D, Hernandez N, Villamanan E, et al
    Concomitant Efficacy of Dupilumab for severe atopic dermatitis and comorbid asthma in real-life conditions.
    J Investig Allergol Clin Immunol. 2022 Jun 20:0. doi: 10.18176/jiaci.0837.
    PubMed    


  17. OLAGUIBEL JM, Sastre J, Rodriguez JM, Del Pozo V, et al
    Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
    J Investig Allergol Clin Immunol. 2022;32:165-180.
    PubMed     Abstract available


  18. QUIRCE S, Trigueros JA, Ausin P, Munoz Cano R, et al
    Role of the different healthcare professionals in the management of asthma patients. The GEMA-FORUM IV task force.
    J Investig Allergol Clin Immunol. 2022 Jun 8:0. doi: 10.18176/jiaci.0833.
    PubMed    


    May 2022
  19. GONZALEZ O, Picado C, Alobid I, Ramirez J, et al
    Eosinophilic sialodochitis: a rare comorbidity of severe asthma.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0817.
    PubMed    


  20. DOMINGUEZ-ORTEGA J, Luna-Porta JA, Olaguibel JM, Barranco E, et al
    Exacerbations among patients with asthma are largely dependent on the presence of multimorbidity.
    J Investig Allergol Clin Immunol. 2022 May 2:0. doi: 10.18176/jiaci.0816.
    PubMed     Abstract available


    April 2022
  21. IZQUIERDO E, Rodriguez-Coira J, Delgado-Dolset MI, Gomez-Casado C, et al
    Epithelial Barrier: Protector and Trigger of Allergic Disorders.
    J Investig Allergol Clin Immunol. 2022;32:81-96.
    PubMed     Abstract available


  22. URIARTE SA, Gronlund H, Wintersand A, Bronge J, et al
    Clinical and Immunologic Changes due to Subcutaneous Immunotherapy With Cat and Dog Extracts Using an Ultrarush Up-Dosing Phase: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2022;32:133-140.
    PubMed     Abstract available


  23. BARROSO B, Valverde-Monge M, Alobid I, Olaguibel JM, et al
    Smell improvement by anti-IgE and anti-IL 5 biologics in patients with CRSwNP and severe asthma. A real life study.
    J Investig Allergol Clin Immunol. 2022 Apr 12:0. doi: 10.18176/jiaci.0812.
    PubMed     Abstract available


    March 2022
  24. SALOMONSSON M, Cardenas EI, Dahlin JS, Kalm-Stephens P, et al
    The proportion of FceRI+ blood monocytes increases with the degree of IgE sensitization in asthma.
    J Investig Allergol Clin Immunol. 2022 Mar 2:0. doi: 10.18176/jiaci.0797.
    PubMed    


    February 2022
  25. MIRALLES LOPEZ JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, et al
    Effectiveness of benralizumab in severe eosinophilic asthma under routine clinical practice.
    J Investig Allergol Clin Immunol. 2022 Feb 11:0. doi: 10.18176/jiaci.0793.
    PubMed    


    January 2022
  26. DELGADO ROMERO J, Blanco-Aparicio M, Cisneros Serrano C, Diaz-Perez D, et al
    Biological therapy at-home administration support for patients with severe asthma BioCart(c).
    J Investig Allergol Clin Immunol. 2022 Jan 24:0. doi: 10.18176/jiaci.0786.
    PubMed    


  27. VALVERDE-MOLINA J, Fernandez-Nieto M, Torres-Borrego J, Lozano Blasco J, et al
    Transition of adolescents with severe asthma from pediatric to adult care in Spain: the STAR consensus.
    J Investig Allergol Clin Immunol. 2022 Jan 12:0. doi: 10.18176/jiaci.0780.
    PubMed     Abstract available


    December 2021
  28. LEIRIA-PINTO P, Carreiro-Martins P, Peralta I, Marques J, et al
    Factors Associated With Asthma Control in 121 Preschool Children.
    J Investig Allergol Clin Immunol. 2021;31:471-480.
    PubMed     Abstract available


  29. DELGADO-ROMERO J, Pereyra-Rodriguez JJ
    Asthma mortality in Spain from 1980 to 2019. Trends and perspectives in new treatment era.
    J Investig Allergol Clin Immunol. 2021 Dec 13:0. doi: 10.18176/jiaci.0771.
    PubMed     Abstract available


    November 2021
  30. ANTONICELLI L, Tontini C, Garritani MS, Piga MA, et al
    Efficacy of mepolizumab in patients with concomitant severe eosinophilic asthma and severe chronic urticaria: an example of personalized medicine?
    J Investig Allergol Clin Immunol. 2021 Nov 29:0. doi: 10.18176/jiaci.0770.
    PubMed    


  31. VALERO A, Molina J, Nuevo J, Simon S, et al
    Economic consequences of the overuse of short-acting beta-adrenergic agonists (SABA) in the treatment of asthma in Spain.
    J Investig Allergol Clin Immunol. 2021 Nov 26:0. doi: 10.18176/jiaci.0767.
    PubMed     Abstract available


  32. KALM-STEPHENS P, Nordvall L, Janson C, Malinovschi A, et al
    Sex differences in baseline risk factors for the incidence of asthma between early adolescence and young adulthood.
    J Investig Allergol Clin Immunol. 2021 Nov 18:0. doi: 10.18176/jiaci.0763.
    PubMed     Abstract available


  33. IZQUIERDO JL, Almonacid C, Campos C, Morena D, et al
    Systemic Corticosteroids in Patients with Bronchial Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021 Nov 11:0. doi: 10.18176/jiaci.0765.
    PubMed     Abstract available


    October 2021
  34. PACHOLCZAK-MADEJ R, Kuszmiersz P, Iwaniec T, Zareba L, et al
    Endothelial Dysfunction and Pentraxin-3 in Clinically Stable Adult Asthma Patients.
    J Investig Allergol Clin Immunol. 2021;31:417-425.
    PubMed     Abstract available


  35. VILLALOBOS-VIOLAN V, Betancor D, Mahillo-Fernandez I, Sastre J, et al
    Nonasthmatic Eosinophilic Bronchitis and Asthma Development: analysis of biomarkers.
    J Investig Allergol Clin Immunol. 2021 Oct 15:0. doi: 10.18176/jiaci.0738.
    PubMed    


  36. LEAL M, Paciencia I, Farraia M, Cavaleiro Rufo J, et al
    Airborne Food Allergen and Aeroallergen Levels in Health Care Settings: An Unaccounted for but Potentially Relevant Source of Exposure?
    J Investig Allergol Clin Immunol. 2021;31:426-432.
    PubMed     Abstract available


    September 2021
  37. DAVILA I, Campo P, Cimbollek S, Almonacid Sanchez C, et al
    Cluster sub-analysis of patients with severe asthma who responded to omalizumab.
    J Investig Allergol Clin Immunol. 2021 Sep 28:0. doi: 10.18176/jiaci.0731.
    PubMed    


    July 2021
  38. ALMONACID SANCHEZ C, Melero Moreno C, Quirce Gancedo S, Sanchez-Herrero MG, et al
    PAGE Study: Summary of a Study Protocol to Estimate the Prevalence of Severe Asthma in Spain Using Big Data Methods.
    J Investig Allergol Clin Immunol. 2021;31:308-315.
    PubMed     Abstract available


    June 2021
  39. PEREZ DE LLANO L, Blanco Cid N, Ortiz Piquer M, Dacal Rivas D, et al
    Compassionate Use of a Single Dose of Benralizumab in a Near-Fatal Asthma Exacerbation.
    J Investig Allergol Clin Immunol. 2021;31:268-270.
    PubMed    


  40. JACOME C, Pereira R, Almeida R, Amaral R, et al
    Validation of App and Phone Versions of the Control of Allergic Rhinitis and Asthma Test (CARAT).
    J Investig Allergol Clin Immunol. 2021;31:270-273.
    PubMed    


  41. BENZECRY V, Pravettoni V, Segatto G, Marzano AV, et al
    Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    J Investig Allergol Clin Immunol. 2021;31:261-263.
    PubMed    


    April 2021
  42. BARRANCO P, Palao P, Ruiz I, Dominguez-Ortega J, et al
    Relationship Between IgE-Mediated Sensitization to Staphylococcus aureus Enterotoxin B, Asthma Severity, and Atopy.
    J Investig Allergol Clin Immunol. 2021;31:170-173.
    PubMed    


  43. DELGADO ROMERO J, Miralles Lopez JC, Alvarez Puebla M, Fernandez Ibanez E, et al
    Severe Asthma Units Accredited by the Spanish Society of Allergology and Clinical Immunology (SEAIC): Experience and Future.
    J Investig Allergol Clin Immunol. 2021;31:182-184.
    PubMed    


  44. DELGADO J, Martinez-Moragon E, Fernandez-Sanchez T
    Factors Affecting the Success of Step-up Therapy in Patients With Moderate-Severe Asthma: A Real-Life Study.
    J Investig Allergol Clin Immunol. 2021;31:145-150.
    PubMed     Abstract available


  45. TEJEDOR-ALONSO MA, Farias-Aquino E, Perez-Fernandez E, Moro-Moro M, et al
    Association Between Severity of Anaphylaxis and Co-occurrence of Respiratory Diseases: A Systematic Review and Meta-analysis of Observational Studies.
    J Investig Allergol Clin Immunol. 2021;31:132-144.
    PubMed     Abstract available


    February 2021
  46. DELGADO J, Davila IJ, Dominguez-Ortega J
    Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.
    J Investig Allergol Clin Immunol. 2021;31:36-43.
    PubMed     Abstract available


  47. MIRALLES LOPEZ JC, Escudero Pastor AI, Carbonell Martinez A, Navarro Garrido C, et al
    Benralizumab in Real Life.
    J Investig Allergol Clin Immunol. 2021;31:87-88.
    PubMed    


  48. PLAZA V, Giner J, Curto E, Alonso-Ortiz MB, et al
    Assessing Adherence by Combining the Test of Adherence to Inhalers With Pharmacy Refill Records.
    J Investig Allergol Clin Immunol. 2021;31:58-64.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: